Literature DB >> 1479317

Trends in "avoidable" mortality in Sweden, 1974-1985.

R Westerling1.   

Abstract

STUDY
OBJECTIVE: The aim was to analyse trends in "avoidable" mortality in Sweden, and to contribute to the methodology of avoidable mortality as an index of the quality of care. SETTING AND PARTICIPANTS: All deaths of Swedish citizens and other residents in Sweden during the period 1974-1985 were analysed as to causes of death between ages 0 and 64 years.
MEASUREMENTS AND MAIN RESULTS: Total mortality delined during the 12 year period studied. Avoidable causes of death were grouped into preventable and treatable causes according to Rutstein's classification. In men, treatable diseases declined more during the 12 year period studied than did total mortality. When lung cancer was excluded, preventable diseases declined for both sexes. Certain avoidable causes of death decreased compared to total mortality, while some others showed an increase. The death rate increased for some avoidable causes of death such as pneumonia other than viral. In women death rates increased for chronic bronchitis and emphysema as well as for malignant neoplasms of trachea, bronchus, and lung, while for boys aged 1-14 years bronchitis NOS and asthma showed an increasing death rate.
CONCLUSIONS: The study indicates that the avoidable mortality method is sensitive enough to describe important changes in the mortality pattern. The explicit definition of treatable and preventable causes of death constitutes a methodological development in epidemiological analysis of this type. Further studies on the quality of care should combine this method with other methods examining the structure and process of health care.

Entities:  

Mesh:

Year:  1992        PMID: 1479317      PMCID: PMC1059638          DOI: 10.1136/jech.46.5.489

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  17 in total

1.  The effect of antibiotics on mortality from infectious diseases in Sweden and Finland.

Authors:  E Hemminki; A Paakkulainen
Journal:  Am J Public Health       Date:  1976-12       Impact factor: 9.308

2.  Avoidable death as a measure of quality.

Authors:  W Holland
Journal:  Qual Assur Health Care       Date:  1990

Review 3.  "Avoidable" mortality and health services: a review of aggregate data studies.

Authors:  J P Mackenbach; M H Bouvier-Colle; E Jougla
Journal:  J Epidemiol Community Health       Date:  1990-06       Impact factor: 3.710

4.  Measuring the quality of medical care. A clinical method.

Authors:  D D Rutstein; W Berenberg; T C Chalmers; C G Child; A P Fishman; E B Perrin
Journal:  N Engl J Med       Date:  1976-03-11       Impact factor: 91.245

5.  Criteria and standards for quality assessment and monitoring.

Authors:  A Donabedian
Journal:  QRB Qual Rev Bull       Date:  1986-03

6.  Better health--but not for all: the Swedish Public Health Report, 1987.

Authors:  F Diderichsen; G Lindberg
Journal:  Int J Health Serv       Date:  1989       Impact factor: 1.663

7.  Changing trends in coronary heart disease mortality; possible explanations.

Authors:  K Pyörälä; F H Epstein; M Kornitzer
Journal:  Cardiology       Date:  1985       Impact factor: 1.869

8.  Medical management and the decline in mortality from coronary heart disease.

Authors:  R Beaglehole
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-04

9.  The effect of health services on mortality: decline in death rates from amenable and non-amenable causes in Finland, 1969-81.

Authors:  K Poikolainen; J Eskola
Journal:  Lancet       Date:  1986-01-25       Impact factor: 79.321

Review 10.  The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle.

Authors:  L Goldman; E F Cook
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

View more
  11 in total

1.  Avoidable mortality in Lithuania.

Authors:  A Gaizauskiene; R Gurevicius
Journal:  J Epidemiol Community Health       Date:  1995-06       Impact factor: 3.710

2.  Trends of mortality in Greece 1980-2007: a focus on avoidable mortality.

Authors:  M Ollandezos; Th Constantinidis; K Athanasakis; Ch Lionis; J Kyriopoulos
Journal:  Hippokratia       Date:  2011-10       Impact factor: 0.471

3.  A confidential inquiry into asthma deaths in Wales.

Authors:  M L Burr; B H Davies; A Hoare; A Jones; I J Williamson; S K Holgate; R Arthurs; I G Hodges
Journal:  Thorax       Date:  1999-11       Impact factor: 9.139

4.  Trends in Belgian premature avoidable deaths over a 20 year period.

Authors:  P C Humblet; R Lagasse; A Levêque
Journal:  J Epidemiol Community Health       Date:  2000-09       Impact factor: 3.710

5.  Avoidable mortality in Europe 1955-1994: a plea for prevention.

Authors:  L Simonato; T Ballard; P Bellini; R Winkelmann
Journal:  J Epidemiol Community Health       Date:  1998-10       Impact factor: 3.710

6.  Avoidable deaths in Sweden, 1997-2018: temporal trend and the contribution to the gender gap in life expectancy.

Authors:  Ali Kiadaliri
Journal:  BMC Public Health       Date:  2021-03-17       Impact factor: 3.295

7.  Differences in avoidable mortality between migrants and the native Dutch in The Netherlands.

Authors:  I Stirbu; A E Kunst; V Bos; J P Mackenbach
Journal:  BMC Public Health       Date:  2006-03-27       Impact factor: 3.295

8.  Avoidable mortality across Canada from 1975 to 1999.

Authors:  Paul D James; Doug G Manuel; Yang Mao
Journal:  BMC Public Health       Date:  2006-05-23       Impact factor: 3.295

9.  The timing of introduction of pharmaceutical innovations in seven European countries.

Authors:  Ragnar Westerling; Marcus Westin; Martin McKee; Rasmus Hoffmann; Iris Plug; Grégoire Rey; Eric Jougla; Katrin Lang; Kersti Pärna; José L Alfonso; Johan P Mackenbach
Journal:  J Eval Clin Pract       Date:  2014-04-22       Impact factor: 2.431

10.  Why is the gender gap in life expectancy decreasing? The impact of age- and cause-specific mortality in Sweden 1997-2014.

Authors:  Louise Sundberg; Neda Agahi; Johan Fritzell; Stefan Fors
Journal:  Int J Public Health       Date:  2018-04-13       Impact factor: 3.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.